OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
AWARE A novel web application to rapidly assess cardiovascular risk in type 2 diabetes mellitus
Cesare Berra, Roberto Manfrini, Marco Mirani, et al.
Acta Diabetologica (2023) Vol. 60, Iss. 9, pp. 1257-1266
Open Access | Times Cited: 4
Cesare Berra, Roberto Manfrini, Marco Mirani, et al.
Acta Diabetologica (2023) Vol. 60, Iss. 9, pp. 1257-1266
Open Access | Times Cited: 4
Showing 4 citing articles:
Underuse of GLP-1 receptor agonists in the management of type 2 diabetes despite a favorable benefit-safety profile
André Scheen
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 7, pp. 797-810
Closed Access | Times Cited: 4
André Scheen
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 7, pp. 797-810
Closed Access | Times Cited: 4
Reply to the letter comment of Su Boon Yong MD, PhD and colleagues to: Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE− 2 study
Cesare Berra, Roberto Manfrini, Francesco Bifari, et al.
Pharmacological Research (2025) Vol. 213, pp. 107640-107640
Open Access
Cesare Berra, Roberto Manfrini, Francesco Bifari, et al.
Pharmacological Research (2025) Vol. 213, pp. 107640-107640
Open Access
Long-term efficacy of daily oral semaglutide as add-on or switch therapy in adults with type 2 diabetes: a 12-month real-world retrospective study
Daniela Sansone, Francesca Garino, Cristina Gottero, et al.
Acta Diabetologica (2025)
Closed Access
Daniela Sansone, Francesca Garino, Cristina Gottero, et al.
Acta Diabetologica (2025)
Closed Access
Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE -2 study
Cesare Berra, Roberto Manfrini, Francesco Bifari, et al.
Pharmacological Research (2024) Vol. 210, pp. 107517-107517
Open Access | Times Cited: 3
Cesare Berra, Roberto Manfrini, Francesco Bifari, et al.
Pharmacological Research (2024) Vol. 210, pp. 107517-107517
Open Access | Times Cited: 3
